A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
Clinical trial NCT03433781 · COMPLETED
Trial details
- NCT number
- NCT03433781
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2022-11-06
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.